ENZ Stock Summary and Trading Ideas (Enzo Biochem Common ($0.01 Par Value) | NYSE:ENZ)

Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. It focuses on delivering and applying its technology to produce products and services to allow its customers to meet their clinical needs. The company has Enzo clinical labs, Enzo life sciences, Enzo therapeutics operating segments. It derives the majority of its revenues from the Clinical lab's segment.

Enzo Biochem Common ($0.01 Par Value) trades on the NYSE stock market under the symbol ENZ.

As of April 25, 2024, ENZ stock price was flat at $1.06 with 17,005 million shares trading.

ENZ has a beta of -0.17, meaning it tends to be less sensitive to market movements. ENZ has a correlation of 0.00 to the broad based SPY ETF.

ENZ has a market cap of $54.30 million. This is considered a Micro Cap stock.

In the last 3 years, ENZ stock traded as high as $4.15 and as low as $1.00.

The top ETF exchange traded funds that ENZ belongs to (by Net Assets): VTI, VXF, DFAT, IWC, DFAC.

ENZ has underperformed the market in the last year with a price return of -58.3% while the SPY ETF gained +22.7%. ENZ has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -18.5% and -12.4%, respectively, while the SPY returned +3.2% and -2.8%, respectively.

ENZ support price is $1.03 and resistance is $1.09 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ENZ stock will trade within this expected range on the day.